Clinical Study

The Purpose Of This Study Is To Evaluate The Effects Of An Investigational Medication On Depression Symptoms, Including Suicidal Thoughts.

Posted Date: Jan 15, 2020

  • Investigator: Melissa Delbello
  • Specialties:
  • Type of Study: Drug

A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Subjects Assessed to be at Imminent Risk for Suicide


12 To <18 Years Of Age, Diagnosed With Mdd Having Current Suicidal Thinking With Intent


Suicide, Depression, Kids

For More Information:

Raechelcooley, Ba

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.